These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 14191030)
1. ACTIVATION OF THE BLOOD FIBRINOLYTIC ENZYME SYSTEM BY PLATELETS. REID WO; SILVER MJ Am J Physiol; 1964 Jun; 206():1255-61. PubMed ID: 14191030 [No Abstract] [Full Text] [Related]
2. THE ROLE OF FIBRINOLYSIN AND PROFIBRINOLYSIN ACTIVATOR IN HEMOPHILIA. REID WO; HOLBURN RR; DESIPIN MT; TOCANTINS LM Am J Med Sci; 1965 May; 249():518-33. PubMed ID: 14280891 [No Abstract] [Full Text] [Related]
3. STUDY OF FIBRINOGEN TURNOVER RATES AFTER TOTAL HEPATECTOMY IN DOGS. GANS H Surgery; 1964 Apr; 55():544-50. PubMed ID: 14138019 [No Abstract] [Full Text] [Related]
5. [THROMBOLYTIC THERAPY AND CHANGES IN FIBRINOLYTIC ACTIVITY]. DOUGLAS AS; MCNICOL GP Recenti Prog Med; 1964 Sep; 37():189-217. PubMed ID: 14229145 [No Abstract] [Full Text] [Related]
6. [THE COMBINED EFFECT OF FIBRINOLYSIS INHIBITORS]. MARKWARDT F; KLOECKING HP; RICHTER M Acta Biol Med Ger; 1964; 12():522-4. PubMed ID: 14134957 [No Abstract] [Full Text] [Related]
7. TISSUE ACTIVATOR OF PLASMINOGEN. LACK CH; ALI SY Nature; 1964 Mar; 201():1030-1. PubMed ID: 14191573 [No Abstract] [Full Text] [Related]
8. THROMBOLYTIC THERAPY. DOUGLAS AS; MCNICOL GP Proc R Soc Med; 1964 Jul; 57(7):609-14. PubMed ID: 14178954 [No Abstract] [Full Text] [Related]
9. INHIBITION OF FIBRINOLYTIC ACTIVITY OF PLASMIN BY VARIOUS SYNTHETIC INHIBITORS. MURAMATU M; ONISHI T; MAKINO S; FUJII S; YAMAMURA Y J Biochem; 1965 Mar; 57():450-3. PubMed ID: 14326102 [No Abstract] [Full Text] [Related]
10. CURRENT PROBLEMS IN HEMOSTASIS. TOCANTINS LM; REID WO; SILVER MJ; KAZAL LA Ann N Y Acad Sci; 1964 Jul; 115():21-30. PubMed ID: 14196071 [No Abstract] [Full Text] [Related]
12. THE INHIBITION OF TRASYLOL OF FIBRINOLYTIC ACTIVITY ASSOCIATED WITH CARDIOVASCULAR OPERATIONS. TICE DA; WORTH MH; CLAUSS RH; REED GH Surg Gynecol Obstet; 1964 Jul; 119():71-4. PubMed ID: 14179354 [No Abstract] [Full Text] [Related]
13. EFFECT OF INHIBITORS OF FIBRINOLYTIC ENZYMES ON DEVELOPMENT OF PULMONARY METASTASES. CLIFFTON EE; AGOSTINO D J Natl Cancer Inst; 1964 Nov; 33():753-63. PubMed ID: 14231149 [No Abstract] [Full Text] [Related]
14. [ANTIPLASMIN ACTIVITY OF THE PANCREATIC TRYPSIN INHIBITOR AND OF EPSILON-AMINOCAPROIC ACID]. DEBARBIERI A; SCEVOLA ME; FRANCHINI M Boll Chim Farm; 1964 Jan; 103():37-40. PubMed ID: 14131376 [No Abstract] [Full Text] [Related]
15. ACTION OF THE NEW ANTI-FIBRINOLYTIC SUBSTANCE ON THE STREPTOKINASE-ACTIVATED PROTEASES (PLASMINS). MIHARA H Kobe J Med Sci; 1963 Dec; 18():169-77. PubMed ID: 14160537 [No Abstract] [Full Text] [Related]
17. ACTIVATION OF PARTIALLY PURIFIED PLASMINOGEN IN THE PRESENCE OF EPSILON-AMINOCAPROIC ACID. A TECHNIQUE FOR PREPARING PLASMIN FREE OF EXTRINSIC ACTIVATORS. DONALDSON VH J Lab Clin Med; 1964 Feb; 63():213-23. PubMed ID: 14125108 [No Abstract] [Full Text] [Related]
18. Interactions of epsilon-aminocaproic acid with the thrombin clotting and fibrinolytic systems. Maxwell RE; Allen D Nature; 1966 Jan; 209(5019):211-3. PubMed ID: 4223693 [No Abstract] [Full Text] [Related]
19. STUDIES ON THE MOLECULAR PATHOLOGY AND PATHOGENESIS OF BLEEDING IN SEVERE FIBRINOLYTIC STATES IN DOGS. KOWALSKI E; BUDZYNSKI AZ; KOPEC M; LATALLO ZS; LIPINSKI B; WEGRZYNOWICZ Z Thromb Diath Haemorrh; 1964 Oct; 12():69-86. PubMed ID: 14224647 [No Abstract] [Full Text] [Related]
20. ACUTE FIBRINOLYTIC STATES IN SURGERY. MCNICOL GP; DOUGLAS AS Proc R Soc Med; 1965 Apr; 58(4):259-61. PubMed ID: 14263735 [No Abstract] [Full Text] [Related] [Next] [New Search]